← back to search

Xueyan Zhou

Wake Forest University · US
Area of research
Physiology · Cellular and Molecular Neuroscience
Research interest
Research focused on Receiver operating characteristic and Hepatocellular carcinoma, with related work in Magnetic resonance imaging, Stage (stratigraphy), Synaptic plasticity. Notable publications include 'Repression of the eIF2α kinase PERK alleviates mGluR-LTD impairments in a mouse model of Alzheimer's disease', 'Dysregulation of Elongation Factor 1A Expression is Correlated with Synaptic Plasticity Impairments in Alzheimer’s Disease', and 'Histogram Analysis of Diffusion-Weighted Magnetic Resonance Imaging as a Biomarker to Predict Lymph Node Metastasis in T3 Stage Rectal Carcinoma'.
h-index
citations
176
works
10
NIH funding
primary concept
email

Recent publications

Apolipoprotein B100 acts as a tumor suppressor in ovarian cancer via lipid/ER stress axis-induced blockade of autophagy
Acta Pharmacologica Sinica 2025cited by 8position: middledoi
Correction to: Histogram analysis based on multi-parameter MR imaging as a biomarker to predict lymph node metastasis in T3 stage rectal cancer
BMC Medical Imaging 2022cited by 3position: middledoi
Histogram Analysis of Diffusion-Weighted Magnetic Resonance Imaging as a Biomarker to Predict Lymph Node Metastasis in T3 Stage Rectal Carcinoma
Cancer Management and Research 2021cited by 19position: middledoi
Histogram peritumoral enhanced features on MRI arterial phase with extracellular contrast agent can improve prediction of microvascular invasion of hepatocellular carcinoma
Quantitative Imaging in Medicine and Surgery 2021cited by 12position: middledoi
Histogram analysis based on multi-parameter MR imaging as a biomarker to predict lymph node metastasis in T3 stage rectal cancer
BMC Medical Imaging 2021cited by 8position: middledoi
Rim enhancement on hepatobiliary phase of pre-treatment 3.0 T MRI: A potential marker for early chemotherapy response in colorectal liver metastases treated with XELOX
European Journal of Radiology 2021cited by 5position: middledoi
Pharmacokinetic analysis of different contrast agents on multiphase enhanced MRI for microvascular invasion: preoperative prediction in hepatocellular carcinoma
Acta Radiologica 2021cited by 2position: middledoi
Computational quantitative measures of Gd-EOB-DTPA enhanced MRI hepatobiliary phase images can predict microvascular invasion of small HCC
European Journal of Radiology 2020cited by 13position: middledoi
Repression of the eIF2α kinase PERK alleviates mGluR-LTD impairments in a mouse model of Alzheimer's disease
Neurobiology of Aging 2016cited by 82position: middledoi
Dysregulation of Elongation Factor 1A Expression is Correlated with Synaptic Plasticity Impairments in Alzheimer’s Disease
Journal of Alzheimer s Disease 2016cited by 24position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Yang Zhou · Guangzhou University of Chinese Medicine7 papers (2020–2022)Xinxin Wang · Harbin Medical University5 papers (2020–2022)JiQing Xing · Chinese PLA General Hospital4 papers (2021–2022)Meng Zhou · Chongqing Medical University3 papers (2021–2022)Tao Ma · New York University2 papers (2016–2016)Eric Klann · New York University2 papers (2016–2016)Ziqian Zhang · South China Agricultural University2 papers (2020–2021)Chunhui Zhang · Nantong University2 papers (2021–2022)Rui Yang · The First Affiliated Hospital, Sun Yat-sen University2 papers (2021–2022)Zeyuan Yin · University of Manchester1 papers (2025–2025)Yang Liu · China National Petroleum Corporation (China)1 papers (2020–2020)Jiamin Zhou · Qingdao University1 papers (2020–2020)Yanyan Yu · Nanchang University1 papers (2021–2021)Xiaochen Yu · Fudan University1 papers (2025–2025)C. Dirk Keene · Seattle Pacific University1 papers (2016–2016)Baishi Hu · University of Illinois Urbana-Champaign1 papers (2025–2025)Hongxin Zhao · Harbin Medical University1 papers (2021–2021)Maggie Donohue · New York University1 papers (2016–2016)Ke Sheng · Central South University of Forestry and Technology1 papers (2025–2025)Helena R. Zimmermann · Wake Forest University1 papers (2016–2016)